Research and Markets: Global Urinary Tract Infection Pipeline Highlights 2014

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/g8mn5p/global_urinary) has announced the addition of the "Global Urinary Tract Infection Pipeline Highlights 2014" report to their offering.

The latest report Urinary Tract Infection Pipeline Highlights 2014, provides most up-to-date information on key pipeline molecules in the global urinary tract infection market. It covers emerging therapies for urinary tract infection in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

  • The report provides urinary tract infection pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

  • The report provides urinary tract infection pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

  • The report provides urinary tract infection pipeline molecules by the Originator Company.

Short-term Launch Highlights:

  • Find out which urinary tract infection pipeline products will be launched in the US and Ex-US till 2017.

Summary

  • Urinary Tract Infection phase 3 clinical trial pipeline molecules
  • Urinary Tract Infection phase 2 clinical trial pipeline molecules
  • Urinary Tract Infection phase 1 clinical trial pipeline molecules
  • Urinary Tract Infection preclinical research pipeline molecules
  • Urinary Tract Infection discovery stage pipeline molecules
  • Urinary Tract Infection pipeline molecules short-term launch highlights

Key Topics Covered:

1. Urinary Tract Infection Pipeline by Stages

2. Urinary Tract Infection Pipeline by Drug Class

3. Urinary Tract Infection Pipeline by Company

4. Urinary Tract Infection Phase 3 Clinical Trial Insights

5. Urinary Tract Infection Phase 2 Clinical Trial Insights

6. Urinary Tract Infection Phase 1 Clinical Trial Insights

7. Urinary Tract Infection Preclinical Research Insights

8. Urinary Tract Infection Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information visit http://www.researchandmarkets.com/research/g8mn5p/global_urinary

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals